Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ladislava Pavlikova is active.

Publication


Featured researches published by Ladislava Pavlikova.


COPD: Journal of Chronic Obstructive Pulmonary Disease | 2013

Skinfold Anthropometry –The Accurate Method for Fat Free Mass Measurement in COPD

Miloslav Hronek; Miroslav Kovarik; Petra Pavlickova Aimova; Vladimir Koblizek; Ladislava Pavlikova; František Salajka; Zdenek Zadak

Abstract Purpose: Fat free mass index (FFMI) is an independent predictor of metabolic and functional consequences in COPD. For its measurement dual energy X-ray absorptiometry (DEXA), skin-fold anthropometry (SFA), bioelectrical impedance analysis (BIA) and bioimpedance spectroscopy (BIS) are used in clinical practice. The aim of our pilot study was to analyse precisely and critically which method is most accurate and available for common use in clinical practice for measurement of FFM by assessment against relevant DEXA in patients with COPD. Methods: This was an observational cross-sectional study of consecutive COPD subjects. FFM by methods of SFA, two versions of BIA, and BIS was compared with that from clinically relevant DEXA in 41 outpatients (mean age 66.5 ± 7.7 yrs) with stable COPD, 34 men and 7 women, with mean BMI 28.2 ± 6.1 kg.m−2. Results: All methods underestimate FFM in comparison with DEXA. In the general evaluation non-significant differences with the smallest mean bias were demonstrated for SFA (1.2 kg) and BIA (3.8 kg), but there was a difference of more than 9 kg using BIS and BIA COPD methods (p < 0.0001). The best agreement between DEXA and SFA was demonstrated via Lins concordance coefficient and Bland–Altman test. Conclusions: SFA has been demonstrated as an accurate, available and cheap method for determination of FFM and FM with application of the Durnin Womersley equation for body density and with the Siri equation for FM in patients with COPD. SFA can be easily applied in routine clinical practice.


Kidney & Blood Pressure Research | 2015

Changes of Serum Calcium, Magnesium and Parathyroid Hormone Induced by Hemodialysis with Citrate-Enriched Dialysis Solution

Roman Safranek; Petr Moucka; Jaroslava Vávrová; Vladimir Palicka; Ladislava Pavlikova; Sylvie Dusilova Sulkova

Background/Aims: In recent years, one of technical attempts to improve biocompatibility and tolerability of the hemodialysis procedure is the substitution of acetate in dialysis solution with citrate. The aim of our study was to compare two dialysis solutions: traditional bicarbonate dialysis solution containing acetate (3 mmol/L) (solution A); and (solution C) commercially produced citrate-enriched bicarbonate dialysis solution (0.8 mmol/L citrate). Methods: Patients from a single hemodialysis center (N=126) were included in the study. Both conventional low-flux hemodialysis and on-line hemodiafiltration procedures were studied. Both dialysis solutions contained identical calcium (1.5 mmol/L) and magnesium (0.5 mmol/L) concentrations. Results: Parathyroid hormone (iPTH) concentration decreased during procedures with solution A by 64%. On the contrary, when solution C was used, iPTH concentration increased insignificantly by 4%. For solution A, serum calcium and magnesium increased during procedures in patients with predialysis concentrations lower than 2.33 and 0.76 mmol/L, respectively. In procedures with dialysis solution C these concentrations were significantly lower: 2.19 mmol/L for Ca and 0.68 mmol/L for Mg. Conclusion: Our study clearly shows that the substitution of part of acetate with citrate in dialysis solution significantly influences changes of serum calcium, magnesium and parathyroid hormone concentrations during hemodialysis and hemodiafiltration procedures.


Pharmacology | 2015

Effect of Mirtazapine on Rat Bone Tissue after Orchidectomy

Sona Fekete; Julius Simko; Martin Mzik; Iva Karesova; Helena Zivna; Ladislava Pavlikova; Vladimir Palicka

Objective: Our study aimed to investigate the effect of mirtazapine on bone metabolism in the orchidectomized rat model. Methods: Rats were divided into three groups. A sham-operated control group (SHAM group) and a control group after orchidectomy (ORX group) received the standard laboratory diet (SLD). An experimental group after orchidectomy (ORX MIRTA group) received SLD enriched with mirtazapine for 12 weeks. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Bone marker concentrations of osteoprotegerin (OPG), amino-terminal propeptide of procollagen type I, bone alkaline phosphatase (BALP), sclerostin and bone morphogenetic protein 2 were examined in bone homogenate. The femurs were used for biomechanical testing. Results: Compared with the control ORX group, we found a lower BMD in the ORX MIRTA group. The differences were statistically significant, although not in the lumbar vertebrae. BMD was lower in the MIRTA group, suggesting a preferential effect on cortical bone. However, although the thickness of the diaphyseal cortical bone was not different, the fragility in the femoral neck area was statistically significantly different between the groups in biomechanical testing. Regarding the bone metabolism markers, there was a significant decrease in OPG and BALP levels, suggesting a reduction in osteoid synthesis. Conclusions: The results suggest that prolonged use of mirtazapine may have a negative effect on the synthesis of bone and on its mechanical strength, especially in the femoral neck. Further studies are warranted to establish whether mirtazapine may have a clinically significant adverse effect on bone exclusively in the model of gonadectomized rats, or whether the effect occurs also in the model of gonadally intact animals and in respective human models.


European Journal of Pharmacology | 2015

Negative effect of serotonin-norepinephrine reuptake inhibitor therapy on rat bone tissue after orchidectomy.

Sona Fekete; Julius Simko; Martin Mzik; Iva Karesova; Helena Zivna; Pavel Zivny; Ladislava Pavlikova; Vladimir Palicka

Our goal was to determine if venlafaxine has a negative effect on bone metabolism. Rats were divided into three groups. The sham-operated control group (SHAM), the control group after orchidectomy (ORX), and the experimental group after orchidectomy received venlafaxine (VEN ORX) in standard laboratory diet (SLD) for 12 weeks. Bone mineral content (BMC) was measured by dual energy X-ray absorptiometry (DXA). Bone marker concentrations of carboxy-terminal cross-linking telopeptide of type I collagen (CTX-I), osteoprotegerin (OPG), amino-terminal propeptide of procollagen type I (P1NP), bone alkaline phosphatase (BALP), sclerostin and bone morphogenetic protein 2 (BMP-2) were examined in bone homogenate. The femurs were used for biomechanical testing. Compared to the ORX group we found lower BMD in the diaphysis area of the femur in the VEN ORX group, suggesting a preferential effect on cortical bone. Of the bone metabolism markers, there was significant decrease (ORX control group versus VEN ORX experimental group) in BALP levels and increase in sclerostin and CTX-I levels, suggesting a decrease in osteoid synthesis and increased bone resorption. The results suggest that the prolonged use of venlafaxine may have a negative effect on bone metabolism. Further studies are warranted to establish whether venlafaxine may have a clinically significant adverse effect on bone.


European Journal of Pharmacology | 2018

The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism

Iva Karesova; Julius Simko; Sona Fekete; Eva Zimcikova; Jana Malakova; Helena Zivna; Ladislava Pavlikova; Vladimir Palicka

&NA; Some data suggest that exposure to levetiracetam (LEV) might be associated with a risk for bone health in the model of orchidectomized rats. The aim of this study was to investigate if there is any significant risk of LEV for bone health in the model of gonadally intact animals. Wistar rats were divided into a control group and a test group, 8 rats in each group. The control rats received standard laboratory diet (SLD) while rats in the test group were fed SLD enriched with LEV for 12 weeks. Dual energy X‐ray absorptiometry was used to measure BMD of the whole body, femur and lumbar vertebrae. The concentrations of bone markers were examined in bone homogenate. Both femurs and tibiae were used for biomechanical testing. We found in the LEV group significantly decreased absolute and relative values of adipose tissue, higher whole‐body BMD, higher right tibia cortical thickness, and a significantly increased concentration of Bone Alkaline Phosphatase (BALP) and cross‐linked C‐telopeptide of type I collagen (CTX‐I) compared with the control group. The results suggest that the long‐term administration of LEV in the model of gonadally intact rats does not have a negative effect on bone. Significant increase in BMD and cortical thickness of the right tibia may indicate even a positive influence on the properties of bone. Further studies will be necessary in animals and humans to confirm these findings.


International Urology and Nephrology | 2015

Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients

Sylvie Dusilová-Sulková; Roman Safranek; Jaroslava Vávrová; Jiří Horáček; Ladislava Pavlikova; Vladimir Palicka


Chest | 2012

Body Composition of COPD Patients Indicated to Ambulatory Pulmonary Rehabilitation Program

Vladimir Koblizek; Sarka Pracharova; Miloslav Hronek; Miroslav Kovarik; Vladimir Palicka; Ladislava Pavlikova; Kamil Klenha; Petr Celakovsky; Jan Brozik; Jana Tuckova


Nephrology Dialysis Transplantation | 2016

MP576SERUM SOLUBLE ALPHA-KLOTHO CONCENTRATIONS ARE NOT DEPENDENT ON VITAMIN D STATUS IN MAINTENANCE DIALYSIS PATIENTS

Sylvie Dusilova Sulkova; Marta Kalousová; Jaroslava Vávrová; Tomáš Zima; Roman Safranek; Eva Vykoukalová; Alena Malá; Ladislava Pavlikova; Vladimir Palicka


Studia pneumologica et phthiseologica | 2015

Distribuce klinických fenotypů v populaci nemocných s těžkou chronickou obstrukční plicní nemocí (pilotní analýza vstupních dat České multicentrické výzkumné databáze těžké CHOPN)

Vladimír Koblížek; Barbora Novotna; Eva Kocova; Patricie Popelkova; Marek Plutinský; Jaromir Zatloukal; T. Dvořák; Ondrej Sobotik; Petr Safranek; Blanka Snelerova; Lucie Heribanova; Pavlina Musilova; Marie Majerciakova; Tomas Vencalek; Karel Hejduk; Rudolf Praus; Magda Vytřísalová; Miloslav Hronek; Miroslav Kovařík Ph.D; Kateřina Neumannová; M. Kopecký; Zuzana Zbožínková; Jiří Jarkovský; Jan Švancara; Ladislava Pavlikova; Tomáš Konečný; Marek Orban; Petr Vanik; Zuzana Liptakova; M. Marel


Postgraduální medicína | 2015

Česká multicentrická výzkumná databáze těžké chronickéobstrukční plicní nemoci - popis projektu

Vladimír Koblížek; Barbora Novotna; Eva Kocova; Patrice Popelkova; Marek Plutinský; Jaromir Zatloukal; Tomáš Dvořák; Ondřej Sobotík; Petr Safranek; Blanka Snelerova; Lucie Heribanova; Pavlina Musilova; Marie Majerciakova; Tomas Vencalek; Karel Hejduk; Rudolf Praus; Magda Vytřísalová; Miloslav Hronek; Miroslav Kovařík Ph.D; Kateřina Neumannová; Michal Kopecký; Zuzana Zbožínková; Jiří Jarkovský; Jan Švancara; Ladislava Pavlikova; Tomáš Konečný; Marek Orban; Petr Vanik; Zuzana Liptakova; Miloslav Marel

Collaboration


Dive into the Ladislava Pavlikova's collaboration.

Top Co-Authors

Avatar

Vladimir Palicka

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Miloslav Hronek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Miroslav Kovarik

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Roman Safranek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Vladimir Koblizek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Barbora Novotna

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Helena Zivna

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Iva Karesova

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jaroslava Vávrová

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge